In Behçet’s disease (BD), a multisystemic inflammatory disorder, TNF-a antagonists are also shown to be effective in patients with major organ involvement, refractory to conventional immunosuppressives (IS) [1]. The gene discussed is TNF; the disease is Behcet disease.